Phreesia Inc (PHR)
Official siteHEALTHCARE • HEALTH INFORMATION SERVICES • NYSE
Market Cap: $787.68M
Last updated: Nov 17, 2026 at 11:05 AM ET
Phreesia Inc (PHR) Financials: Revenue, Profit and Cash Flow
Phreesia reported revenue of $480.59M for the fiscal year ended Jan 31, 2026, up 14.5% from the year before. That year, net income was $2.31M with a net margin of 0.5%, operating cash flow was $78.81M and free cash flow was $54.42M. The quarter ended Jul 31, 2026 had revenue of $129.46M and net income of $1.92M.
Revenue and Margins
The operating margin was -1.4% in the fiscal year ended Jan 2026, the highest of the 9 years shown. Over the 8 years to Jan 2026, revenue grew from $79.83M, a compound annual rate of 25.2%.
| Fiscal year | Revenue | Growth | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|---|
| Jan 2026 | $480.59M | +14.5% | 85.2% | -1.4% | 0.5% |
| Jan 2025 | $419.81M | +17.8% | 84.2% | -13.8% | -13.9% |
| Jan 2024 | $356.30M | +26.8% | 82.9% | -38.3% | -38.4% |
| Jan 2023 | $280.91M | +31.7% | 61.1% | -62.9% | -62.7% |
| Jan 2022 | $213.23M | +43.4% | 61.8% | -54.8% | -55.4% |
| Jan 2021 | $148.68M | +19.1% | 64.8% | -17.3% | -18.4% |
| Jan 2020 | $124.78M | +24.9% | 64.2% | -12.3% | -16.3% |
| Jan 2019 | $99.89M | +25.1% | 63.0% | -9.5% | -15.1% |
| Jan 2018 | $79.83M | N/A | 62.7% | -18.2% | -22.8% |
Income Statement
In the fiscal year ended Jan 2026, net income turned positive after a loss the year before. In the quarter ended Jul 2026, net income rose 193.6% from the same quarter a year earlier.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $480.59M | $419.81M | $356.30M | $280.91M | $213.23M | $148.68M | $124.78M | $99.89M | $79.83M |
| Cost of revenue | $71.36M | $66.23M | $61.02M | $109.27M | $81.39M | $52.39M | $44.72M | $37.00M | $29.77M |
| Gross profit | $409.23M | $353.59M | $295.27M | $171.64M | $131.84M | $96.29M | $80.06M | $62.89M | $50.06M |
| Research and development | $121.48M | $117.36M | $112.35M | $91.24M | $52.27M | $22.62M | $18.62M | $14.35M | $11.38M |
| Operating income | -$6.61M | -$58.10M | -$136.48M | -$176.55M | -$116.82M | -$25.67M | -$15.30M | -$9.49M | -$14.55M |
| Net income | $2.31M | -$58.53M | -$136.88M | -$176.15M | -$118.16M | -$27.29M | -$20.29M | -$15.06M | -$18.19M |
| EBITDA | $31.34M | -$26.20M | -$105.57M | -$149.42M | -$93.09M | -$7.35M | -$3.28M | $2.47M | -$2.62M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $129.46M | $130.94M | $127.07M | $120.33M | $117.25M | $115.94M | $109.68M | $106.80M | $102.11M | $101.22M | $95.00M | $91.62M |
| Gross profit | $110.19M | $113.28M | $169.44M | $82.31M | $99.86M | $99.30M | $144.82M | $72.26M | $69.30M | $67.20M | $126.22M | $60.68M |
| Operating income | $7.61M | $6.75M | -$5.56M | $3.74M | -$1.51M | -$3.29M | -$7.61M | -$13.84M | -$17.22M | -$19.42M | -$29.58M | -$32.05M |
| Net income | $1.92M | $2.96M | $1.29M | $4.27M | $654.00K | -$3.91M | -$6.39M | -$14.40M | -$18.01M | -$19.72M | -$30.65M | -$31.94M |
Balance Sheet
As of Jan 2026, total debt of $100.09M exceeded cash and equivalents by $26.26M.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $663.79M | $388.42M | $370.33M | $370.06M | $494.48M | $326.67M | $158.76M | $59.26M | $57.14M |
| Current assets | $279.84M | $203.28M | $195.68M | $262.44M | $386.35M | $272.27M | $131.54M | $33.32M | $35.95M |
| Cash and equivalents | $73.83M | $84.22M | $87.52M | $176.68M | $313.81M | $218.78M | $90.31M | $1.54M | $10.50M |
| Total liabilities | $326.58M | $123.61M | $118.88M | $82.24M | $77.20M | $63.36M | $56.89M | $63.75M | $224.82M |
| Short-term debt | $7.97M | $8.04M | $6.06M | $5.17M | $5.82M | $4.86M | $2.32M | $1.97M | $2.83M |
| Long-term debt | $92.12M | $8.15M | $5.40M | $2.73M | $7.42M | $6.47M | $21.54M | $27.92M | $19.45M |
| Shareholder equity | $337.21M | $264.81M | $251.45M | $287.82M | $417.28M | $263.31M | $101.86M | -$210.97M | -$167.68M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $646.98M | $666.14M | $663.79M | $423.47M | $408.63M | $400.39M | $388.42M | $375.70M | $362.24M | $372.09M | $371.08M | $374.65M |
| Total liabilities | $275.13M | $307.05M | $326.58M | $103.14M | $110.64M | $118.21M | $123.61M | $121.11M | $110.90M | $119.34M | $119.64M | $110.05M |
| Cash and equivalents | N/A | $74.71M | $73.83M | $106.37M | $98.27M | $90.87M | $84.22M | $81.74M | $81.80M | $79.53M | $87.52M | $103.37M |
| Shareholder equity | $371.85M | $359.09M | $337.21M | $320.33M | $297.99M | $282.19M | $264.81M | $254.59M | $251.34M | $252.74M | $251.45M | $264.60M |
Cash Flow
In the fiscal year ended Jan 2026, free cash flow was 69.1% of operating cash flow.
Annual
| Line item | Jan 2026 | Jan 2025 | Jan 2024 | Jan 2023 | Jan 2022 | Jan 2021 | Jan 2020 | Jan 2019 | Jan 2018 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $78.81M | $32.38M | -$32.38M | -$90.12M | -$74.71M | $2.89M | $826.00K | -$2.13M | -$11.14M |
| Capital expenditures | $24.40M | $24.09M | $25.10M | $26.20M | $30.80M | $18.57M | $12.32M | $9.83M | $11.96M |
| Free cash flow | $54.42M | $8.29M | -$57.48M | -$116.33M | -$105.52M | -$15.69M | -$11.49M | -$11.96M | -$23.11M |
| Dividends paid | N/A | N/A | $12.18M | N/A | $0 | $4.96M | $14.96M | $0 | $0 |
| Share repurchases | N/A | N/A | N/A | N/A | N/A | $290.00K | $6.22M | $195.00K | $0 |
| Investing cash flow | -$161.88M | -$24.09M | -$39.67M | -$26.20M | -$65.23M | -$25.09M | -$12.32M | -$11.02M | -$11.96M |
| Financing cash flow | $72.85M | -$11.49M | -$17.11M | -$20.80M | $234.97M | $150.66M | $100.27M | $4.19M | $31.29M |
Quarterly
| Line item | Jul 2026 | Apr 2026 | Jan 2026 | Oct 2025 | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 | Apr 2024 | Jan 2024 | Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $18.33M | $23.92M | $33.66M | $15.47M | $14.84M | $14.85M | $16.26M | $5.79M | $11.06M | -$721.00K | -$3.08M | -$6.31M |
| Capital expenditures | $4.50M | $7.55M | $5.14M | $6.67M | $5.20M | $7.39M | $7.06M | $4.18M | $7.40M | $5.45M | $7.86M | $5.31M |
| Free cash flow | $13.82M | $16.37M | $28.52M | $8.80M | $9.63M | $7.46M | $9.20M | $1.60M | $3.66M | -$6.17M | -$10.94M | -$11.62M |
Frequently Asked Questions About PHR
What is Phreesia's annual revenue?
Phreesia reported revenue of $480.59M for the fiscal year ended Jan 31, 2026.
How fast is Phreesia's revenue growing?
Revenue was up 14.5% for the fiscal year ended Jan 31, 2026 compared with the year before. The compound annual revenue growth rate over 3 years was 19.6%.
Is Phreesia profitable?
Yes. Phreesia reported net income of $2.31M for the fiscal year ended Jan 31, 2026, with a net margin of 0.5%.
How much free cash flow does PHR generate?
For the fiscal year ended Jan 31, 2026, operating cash flow of $78.81M minus capital expenditures of $24.40M produced free cash flow of $54.42M.
How much debt does Phreesia have?
The balance sheet dated Jan 31, 2026 reported long-term debt of $92.12M, short-term debt of $7.97M and cash and equivalents of $73.83M.
PHR pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors